|
Isotretinoin Clinical Trials
3 actively recruiting trials across 1 location
Also known as: 13-cRA, 13-cis retinoic acid, 13-cis-Retinoate, 13-cis-Retinoic Acid, 13-cis-Vitamin A Acid +22 more
Pipeline
Early 1: 1Phase 3: 2
Top Sponsors
- National Cancer Institute (NCI)1
- Children's Oncology Group1
- C17 Council1
Indications
- Neuroblastoma3
- Cancer3
- Ganglioneuroblastoma, Nodular2
- CNS Embryonal Tumor, Nos1
- CNS Embryonal Tumor With Rhabdoid Features1
Birmingham, Alabama2 trials
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Children's Hospital of Alabama
Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Hospital of Alabama
Phase 3
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.